Login / Signup
James Melhorn
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 3
Top Topics
Study Protocol
Lung Function
Chronic Obstructive Pulmonary Disease
Monoclonal Antibody
Top Venues
JMIR research protocols
Respirology (Carlton, Vic.)
Thorax
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
James Melhorn
,
Gabriel Lavoie
Uncontrolled mild-to-moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping.
Respirology (Carlton, Vic.)
(2024)
Imran Howell
,
Mahdi Mahdi
,
Mona Bafadhel
,
Timothy Stopford Christopher Hinks
,
Sanjay Ramakrishnan
,
James Melhorn
,
Maisha F Jabeen
,
Ian Douglas Pavord
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST).
JMIR research protocols
12 (2023)
Simon Couillard
,
Annette Laugerud
,
Maisha F Jabeen
,
Sanjay Ramakrishnan
,
James Melhorn
,
Timothy Stopford Christopher Hinks
,
Ian Douglas Pavord
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.
Thorax
(2021)